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Type IV pili (Tfp) of Neisseria gonorrhoeae, the Gram-negative
etiologic agent of gonorrhea, facilitate colonization of the human
host. Tfp are assumed to play a key role in the initial adherence to
human epithelial cells by virtue of the associated adhesin protein
PilC. To examine the structural and functional basis for adherence
in more detail, we identified potential genes encoding polypep-
tides sharing structural similarities to PilE (the Tfp subunit) within
the N. gonorrhoeae genome sequence database. We show here
that a fiber subunit-like protein, termed PilV, is essential to or-
ganelle-associated adherence but dispensable for Tfp biogenesis
and other pilus-related phenotypes, including autoagglutination,
competence for natural transformation, and twitching motility.
The adherence defect in pilV mutants cannot be attributed to
reduced levels of piliation, defects in fiber anchoring to the
bacterial cell surface, or to unstable pilus expression related to
organelle retraction. PilV is expressed at low levels relative to PilE
and copurifies with Tfp fibers in a PilC-dependent fashion. Purified
Tfp from pilV mutants contain PilC adhesin at reduced levels. Taken
together, these data support a model in which PilV functions in
adherence by promoting the functional display of PilC in the
context of the pilus fiber.
The adherence of microbes to host tissue represents the initialstep in the pathogenesis of infections, with specificity and
tissue tropism being defined by precise adhesin-receptor inter-
actions. In most Gram-negative pathogens that colonize mucosal
surfaces, attachment is mediated by proteinaceous filaments
termed pili or fimbriae (1). The use of these organelles to display
adhesive molecules promotes ligand recognition at a distance
from the bacterial cell surface. This increase in the effective
physical range of interaction allows the pathogen to maintain
dense surface structures such as polysaccharide capsules and
LPS, which act in immune avoidance.
The structure–function relationships of adhesive pili are best
understood for those pili assembled by the chaperone-assisted or
chaperoneusher pathway, which accounts for over 30 distinct
forms of adhesive organelles in various Gram-negative species
(2). These pili are composite structures with a long pilus shaft
comprised of the major pilus subunit and a short tip fibrillum
made up of pilin-subunit-like molecules, including the actual
adhesin and adaptors that link it to the shaft. Type IV pili (Tfp)
are a separate unique class of pili expressed by many Gram-
negative bacteria of medical, environmental, and industrial
importance. Tfp are defined by their shared structural, biochem-
ical, antigenic, and morphological features (3) and a highly
conserved biogenesis pathway that resembles that used for the
Type II protein secretion pathway (4).
Tfp promote adherence of Neisseria gonorrhoeae, the Gram-
negative etiologic agent of gonorrhea, to epithelial cells and
therefore play a crucial step in colonization of the human host
(5). They also contribute to other phenotypes, including auto-
agglutination, competence for natural transformation, and
twitching motility (6). Tfp-mediated gonococcal adherence ap-
pears not to be directly associated with the pilin subunit protein
PilE but rather is most strongly correlated with the expression of
the less abundant PilC protein, which copurifies with Tfp (7, 8).
A similar system appears to operate for the highly related species
Neisseria meningitidis. In contrast, Tfp-mediated adherence ex-
hibited by Pseudomonas aeruginosa has been proposed to involve
a receptor-binding site within the C terminus of the pilin subunit
(9). Tfp also enhance colonization of human epithelium by
enteropathogenic strains of Escherichia coli (10) and Vibrio
cholerae (11), but is unclear whether specific adhesin–receptor
interactions are involved in these species.
The conclusion that PilC is a neisserial Tfp-associated adhesin
is based primarily on the findings that (i) purified recombinant
PilC imparts human epithelial cell binding activity on latex beads
to which it has been coupled and blocks binding of piliated
organisms to human epithelial cells (7) and (ii) piliated mutants
lacking PilC fail to adhere (12, 13). However, several studies have
suggested a role for the pilin subunit PilE in receptor recogni-
tion. These include numerous findings showing that different
antigenic variant forms of PilE influence epithelial cell adher-
ence and tissue tropism (12, 14–16). However, the structural and
functional attributes of PilE accounting for these observations
remain unknown. Additionally, PilE itself has been reported to
possess human epithelial cell and erythrocyte receptor binding
properties (8, 17). The biological significances of the latter in
vitro activities to pilus and gonococcal cell adherence remain
unclear.
In an effort to understand the molecular biology of neisserial
Tfp in more detail, we undertook a project to identify potential
genes encoding polypeptides sharing structural similarities to
PilE (the Tfp subunit) within the neisserial genome sequence
databases. We previously reported on the characterization of
one such protein, ComP, which is dedicated to the DNA uptake
process associated with Tfp expression (18). Here, we identify
and characterize a second protein, termed PilV, which is essen-
tial to Tfp-mediated adherence to human epithelial cells but
dispensable for organelle biogenesis and other pilus-related
phenotypes. The data are most consistent with PilV being a
minor constituent of the Tfp fiber, and we propose that it acts
indirectly in adherence by promoting the effective display of the
associated PilC adhesin.
Materials and Methods
Bacterial Strains, Plasmids, and DNA Manipulations. Bacterial strains
used in this study are described in Table 1. E. coli HB101 was
used for plasmid propagation and cloning experiments. Antibi-
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otics were used for selection of gonococcal transformants at the
following concentrations: chloramphenicol, 10 gml; erythro-
mycin, 8 gml; kanamycin, 50 gml; nalidixic acid, 1 gml;
and tetracycline, 15 gml. Isolation and purification of plasmid
DNA were performed by using Qiagen columns according to the
manufacturer’s specifications (Qiagen, Chatsworth, CA).
Based on DNA sequence derived from FA1090 genome
project, the pilV locus was amplified by using primers PilV5
(5-GTCGAGCTCGAATTCTTTAACCAAACCGATGAAA-
3) and PilV3 (5-GTCGAGCTCGGATCCGGGCTTCA-
GATAAGACCATCC-3). The resulting 1.2-kb PCR fragment
was cut by using the unique flanking BamHI and EcoRI sites
(underlined) and forced cloned into pUP6 (19) to yield pPILV1.
For the complementation studies, cloning of pilV into p2161
was done by using the same oligonucleotides, but here the
resulting product was cut with the flanking SacI sites (shown in
italics) and cloned into a unique SacI site in the vector. p2161
is a derivative of pUP6 that allows insertion of DNA fragments
into the iga locus (4). The nucleotide sequence of pilV and pilE
alleles was determined directly from PCR products at GATC
Biotech AG (Konstanz, Germany). A pilV insertion mutant was
constructed by cloning a kanamycin resistance gene cassette into
the unique XhoI site at codons L 4E 5 of PilV in pPilV1 to
yield pPILV2. A frame-shift mutation was made by PCR by using
the oligonucleotide PilV3 together with PilV-FS (5-
AGCTCGAGCAGCGTAAAGCTTTTGAACGTTTTTCA-
TAGC-3). This primer overlaps the XhoI site (bold) in PilV,
deleted a single base at the G 1 codon and introduced a new
restriction enzyme site (HindIII, underlined) that was used for
verification of the frame-shift mutation when transformed into
gonococcal strains. The PCR product was cut with XhoI and
BamHI and ligated into pPilV1 digested with these same en-
zymes creating the plasmid pPILV3.
Characterization of Twitching Motility and Competence for Natural
Transformation. Twitching motility was assessed by direct visual-
ization of bacteria at the periphery of colonies with a stereomi-
croscope, as well as by the slide culture method in which bacteria
grown on Gc agar slices on microscope slides are covered with
a coverslip and viewed in a Zeiss phase microscope by using the
40 objective (19). Transformation assays were carried out as
previously described by using 1 gml plasmid pSY6 DNA (19).
Epithelial Cell Bacterial Adherence and Tfp Binding Assays. Primary
cultures of human corneal epithelial cells were established as
described (20). For use in adherence assays, epithelial cells were
grown on 12-mm circular glass or thermanox coverslips in 1 ml
of medium. Before the start of the infection, the medium was
replaced with 1 ml of DMEM supplemented with 5% FCS.
Gonococci were grown on GC agar plates (14 h, 5% CO2),
suspended in tissue culture medium, and added to the cells (2 
107 per well). After 1 h incubation (37°C, 10% CO2), the
infection was stopped by rinsing the cells three times with 1 ml
Dulbecco’s PBS (DPBS) to remove unbound microorganisms,
followed by fixation (at least 30 min, room temperature) in 0.1%
glutaraldehyde1% paraformaldehyde in DPBS. Specimens
were stained with crystal violet (0.007% in distilled water).
Infected cells were photographed by using an Olympus (New
Hyde Park, NY) BH-2 microscope, and photoprints were directly
counted to determine the number of adherent bacteria per cell.
In cases where large numbers of adherent bacteria and micro-
colony formation precluded accurate counting, quantitation of
adherence was confirmed as follows: after 1 h, nonadherent
bacteria were removed by washing five times with assay media.
The monolayers and cell-associated bacteria were then recov-
ered by treatment with 0.25% trypsin for 5 min at 37°C. The
recovered bacteria were plated on agar after dilution, and
relative adherence was quantified by determining the ratio of
cell-associated colony-forming units (cfu) to total cfu of the
inoculum. Tfp binding assays were performed similarly, with the
exception that the resuspended gonococci (one plate per milli-
liter of tissue culture medium) were vigorously vortexed (1 min)
to shear off Tfp, which were separated from the bacteria by
differential centrifugation (13,000  g, 3 min) and added to the
human epithelial cells. After 2 h of incubation at 37°C, the cells
were washed and fixed in 2% paraformaldehyde in DPBS (30
min). Bound Tfp were detected by indirect immunofluorescence
by using first rabbit serum 2-66 [1500 dilution in Tris-buffered
saline containing 1% BSA (pH 7.2)] raised against purified Tfp
from strain N400, followed by staining with Alexa Red (594 nm)
conjugated goat anti-rabbit IgG (Molecular Probes; 1400 dilu-
tion in the same buffer). Specimens were mounted in 50%
glycerol in DPBS and viewed in a conventional Zeiss f luores-
cence microscope and by confocal laser microscopy. Images
shown correspond to fields that are representative of the overall
observations.
Protein Quantitation. Total cellular protein was extracted by
incubating resuspended gonococcal cell pellets in lysis buffer (0.2
M potassium phosphate buffer (pH 7.5), 20% acetone, 40 mM










N400 VD300 recA6(tetM)    (13)
N401 N400 recA6(kan)    (13)
MW4 N401 pilTind(tetM)    (13)
MW7 N401 pilTind, pilC1erm, pilC2cat    (13)
GV1 N400 pilVG-1 fs    This work
GV2 N400 pilVkan    This work
GV3 GV2 pilVkan, igapilV    This work
GV4 MW4 pilVkan, pilTind    This work
GV5 GV1 pilVG-1 fs, igapilV    This work
GV6 MW4 pilVG-1 fs, pilTind    This work
GC1† N401 pilC1erm   ND This work
C2† GC1 pilC1erm, pilVG-1 fs   ND This work
C3† C2 pilC1erm, pilVG-1 fs, pilTind   ND This work
GV7 C3 pilC1erm, pilVG-1 fs, pilTind, pilC2cat    This work
*HCEC, human corneal epithelial cells; , 100 cfucell; , 0–5 cfucell. Results are expressed as the mean values of at least four independent experiments.
†These strains were generated in the stepwise creation of GV7.































EDTA, and 0.1% Triton X-100) for 15 min on ice. Protein
concentrations were determined by using the Bio-Rad Protein
Assay and BSA standards according to the manufacturer’s
instructions.
SDSPAGE, Immunoblotting, and Staining. Procedures for SDS
PAGE and immunoblotting have been described previously (13).
Quantitative pilus purification was carried out as previously
described (13). PilV and PilC were detected by immunoblotting
of pilus preps and whole cell lysates by using PilV- and PilC-
specific rabbit polyclonal antibodies and alkaline phosphatase-
coupled goat anti-rabbit antibodies (Tago). PilC-specific sera
were gifts from A.-B. Jonsson (Karolinska Institutet, Stockholm)
and T. Rudel (Max Planck Institute for Infection Biology,
Berlin). PilV-specific antisera were generated against a synthetic
peptide (QNLERYYRQKGTFEKYDSTKL) corresponding to
amino acid residues 45–65 of the mature protein (Research
Genetics, Huntsville, AL). The pilin subunit from purified pili
was detected by Coomassie staining of SDSPAGE gels. A
colloidal silver staining technique was used to detect proteins on
poly(vinylidene difluoride) membranes (21).
Electron Microscopy. Colonies of bacteria grown on GC agar plates
(12 h, 37°C, 5% CO2) were gently touched with pioloform-coated
grids and air dried. Grids were subsequently stained with 1%
ammonium molybdate in water for 2 min, rinsed once with water,
air-dried, and viewed in a Hitachi (Tokyo) HU-11E-1 electron
microscope. Images shown correspond to fields that are repre-
sentative of the overall observation.
Results
Identification of a Gonococcal Prepilin-Like ORF. By using a database
search strategy previously successful in the identification of the
comP locus (18), we identified a second ORF sharing identity to
the N terminus of PilE in the FA1090 gonococcal genome
sequence assembled at the University of Oklahoma. To charac-
terize this ORF in more detail, the locus was PCR amplified from
strain N400 and sequenced. The derived ORF differed only
slightly from the FA1090 ORF and was predicted to encode a
polypeptide of 129 aa with a pI of 9.3 and molecular mass of 14.35
kDa. Comparative sequence analysis found homologues in the
meningococcal group A (22) and B (23) genome sequences
(corresponding to NMA0726 and NMB0547, respectively), with
82% identical sequence over their complete reading frames. The
sequence downstream of the predicted translation termination
site demonstrated a strong potential to form a stable stem loop
RNA structure, and further examination of the sequences up-
stream and downstream showed sequence similarity to genes
encoding an AcrE-like lipoprotein and alcohol dehydrogenase,
respectively (data not shown). The organization of this gene
cluster is conserved in N. meningitidis strains (22, 23).
In a BLASTP search of the GenBank database, the ORF showed
the highest identity to several Tfp subunits from various bacterial
species (Fig. 1), with the regions of relatedness limited to the first
35 residues. Although the degree of identity within residues 1
through 27 was very high, the ORF did differ from a consensus
sequence at residues 4, 9, 17, 18, and 25 (Fig. 1).
PilV Mutants Are Defective in Adherence to Human Epithelial Cells.
Both a gene disruption and a frameshift mutation (which altered
residues carboxyl terminal to E 5 and G 1, respectively; see
Materials and Methods) were constructed and introduced into the
gonococcal chromosome via transformation. The mutants were
indistinguishable from the wild-type parent in Tfp-associated
colony morphology, retained the pilus-associated phenotype of
twitching motility, and were not quantitatively reduced in com-
petence for transformation relative to the isogenic wild-type
parent (Table 1). In contrast, adherence assays showed that the
mutants were severely impaired, with the levels of adherence
being reduced 100-fold relative to the wild-type strains (Fig. 2,
Top; Table 1). The defects in binding exhibited by the mutants
Fig. 1. N-terminal aligment of PilV with Tfp prepilins. The arrow indicates the prepilin peptidase processing site of the prepilin proteins and predicted processing
site of PilV. Identical residues are boxed and in bold.
Fig. 2. Adherence of gonococcal strains and Tfp to human corneal epithelial
cells. (Top and Middle) Adherent cells are stained with crystal violet. wt (N400;
recA6(tetM)); pilV (GV2; pilV::kan); pilT (MW4; pilTind(tetM)); and PilT, pilV
(GV4; pilV::kan, pilTind). (Bottom) Binding of Tfp to human corneal epithelial
cells assesed by indirect immunofluorescence. wt (N400; recA6(tetM)); and
pilV (GV2; pilV::kan). All panels are shown at the same level of magnification.























were successfully complemented by introduction of an intact
copy of the ORF region and adjacent 5 sequences into the iga
locus encoding IgA1 protease (Table 1). These results excluded
the possibility that the binding deficiency could be due to
polarity effects on distal gene expression. To exclude the pos-
sibility that the impaired adherence was due to PilE antigenic
variation, the pilE genes in the mutants were sequenced and
found to be unaltered. Based on these results and findings
detailed below, the corresponding gene was named pilV.
The simplest explanation for the nonadherent mutant pheno-
type would be a defect in Tfp fiber formation, although the
autoagglutinating colony morphology of the pilV mutants sug-
gested that they expressed Tfp at undiminished levels. Exami-
nation by transmission electron microscopy confirmed that the
pilV mutants retained piliation levels indistinguishable from wild
type (Fig. 3 Left). At this level of resolution, no altered pilus fiber
morphology or lateral aggregation was discernible. To assess
directly relative levels of piliation, a quantitative purification
method previously developed was used (13). As shown in Fig. 4B,
the yields of pili from the pilV mutants were indistinguishable
from those from the wild-type parent and the complemented
strains when standardized relative to the weights of whole cells
used in purification.
Gonococcal pili are dynamic structures that undergo both
extrusion from the cell and retraction (4, 24). Pilus retraction
accounts for the absence of pilus fibers in some classes of
biogenesis mutants (4, 13) and has been proposed to be respon-
sible for the dramatic reduction in piliation seen after prolonged
interaction of N. meningitidis with a human epithelial cell line
(25). It appears then that, under certain circumstances, the
equilibrium between pilus growth and retraction can be shifted
from one in which extrusion is favored to one in which retraction
predominates. It was formally possible then that the adherence
defects in pilV mutants might relate to altered kinetics of
retraction during interactions with human epithelial cells. We
therefore asked whether blocking pilus retraction would rescue
the adherence defect in pilV mutants by introducing a nonfunc-
tional allele of pilT, whose product is required for retraction (4)
into those backgrounds. These pilT, pilV strains expressed Tfp at
the same level as the isogenic pilT strains (data not shown), and
no alterations in pilus fiber morphology were seen between the
isogenic pairs (Fig. 3 Right). Like the isogenic pilT mutant, the
double mutants hyperautoagglutinated (data not shown), did not
express twitching motility, and failed to take up DNA during
transformation (Table 1). When tested for adherence, however,
the pilT, pilV mutants failed to adhere to the human cells
whereas the pilT mutant bound efficiently (Fig. 2 Middle; Table
1). Therefore, altered dynamics of pilus retraction do not
appear to be responsible for aberrant adherence found for the
pilV mutants.
Virji and colleagues (26) reported reduced epithelial cell
binding capabilities in N. meningitidis because of a pilus anchor-
age defect associated with low level expression of PilC. To
address whether a related phenomenon might be operating in
pilV mutants, crude Tfp preparations (obtained from bacterial
suspensions that were subjected to shearing by vortexing and
cleared by low speed centrifugation) were incubated with the
human epithelial cells. As detected by indirect immunofluores-
cence, wild-type Tfp bound efficiently to the cell monolayers
whereas pilV::kan Tfp were present in greatly reduced amounts
(Fig. 2 Bottom). As such, PilV appears to contribute to the
intrinsic epithelial cell adhesiveness of gonococcal Tfp.
PilV Copurifies with Pilus Fibers. To identify PilV and assess its
pattern of expression and localization, polyclonal rabbit serum
raised against a synthetic peptide representing residues 45–65 of
the mature protein was used in immunoblotting. This serum
detects PilV as a Mr 18 kDa polypeptide when expressed in E.
coli (data not shown). By using whole cell gonococcal lysates, a
Fig. 3. Piliation of gonococcal strains analyzed by transmission electron
microscopy. wt (N400, recA6(tetM)); pilV (GV2, pilV::kan); pilT (MW4, pilTind
(tetM)); and pilT, pilV (GV4, pilV::kan, pilTind). Micrographs are taken at a
magnification of 90,000.
Fig. 4. Quantitative analysis of PilV and PilC in whole cells and purified pili
from gonococcal strains. Lanes 1, N401 (wt); 2, GV1 (pilVG-1 fs); 3, GV2
(pilV::kan); 4, GV3 (pilV::kan, iga::pilV); 5, MW4 (pilTind); 6, MW7 (pilTind,
pilC1::erm, pilC2::cat); and 7, GV7 (pilVG-1 fs,, pilTind, pilC1::erm, pilC2::cat). (A)
Immunoblotting of whole cell lysates by using rabbit antibodies specific for
PilV. (B) Coomassie-stained SDSPAGE gel showing the relative amounts of
PilE in purified pili. (C) Immunoblotting of purified pili by using rabbit anti-
bodies specific for PilV. (D) Immunoblotting of purified pili by using rabbit
antibodies specific for PilC. (E) Detection of PilC by colloidal silver staining of
purified pilus proteins transferred to a poly(vinylidene difluoride) membrane.
The amounts of samples loaded in A were equalized based on the total protein
concentration of whole cells. The amounts of purified pili loaded in B–E, lanes
1 through 4, were standardized based on the weight of whole cells from which
the preparations were made. The comparable intensities of the Coomassie-
stained PilE band in B (reflecting its relative yield) provide a quantitative
readout of piliation levels (19). The amounts of pili loaded in lanes 5–7 were
adjusted to be equivalent to those used in lanes 1–4.































similar reactive species migrating with molecular mass of 18 kDa
was present in the wild-type background and absent in the pilV
mutant strains GV1 (pilVG-1 fs) and GV2 (pilV::kan; Fig. 4A).
Antigen detection was restored in the mutants complemented
with pilV expressed from the iga locus. Knowing where PilV
migrated on SDSPAGE, we attempted to localize it in by using
Coomassie-stained gels of whole cell lysates, but no specific band
was detected (data not shown). Thus, PilV appears to be
expressed at relatively low levels.
Yoshida and colleagues (27) previously demonstrated the
copurification of the pilin-like PilV protein with thin Tfp en-
coded by IncI1 plasmids. We used immunoblotting to see
whether PilV might also copurify with Tfp fibers and found it
present in equivalent levels in pilus preparations from the
wild-type and complemented pilV mutant but at approximately
2-fold reduced levels in the pilT mutant preparations (Fig. 4C).
We sought to detect PilV in Coomassie-stained gels loaded with
the purified pilus preparations but could not detect a corre-
sponding band (data not shown), demonstrating that PilV is
present at low levels in purified Tfp preparations.
PilC and PilV Content in Pilus Preparations from Adherence-Defective
Mutants. One potential explanation for the lack of adherence of
pilV mutants to human epithelial cells would be that PilV is
required for PilC stability, activity, or localization. We first
examined the status of PilC antigen in whole cell lysates by
immunoblotting but could detect no differences within any of the
strains used here save for its absence in the pilC mutants (data
not shown). However, when purified Tfp preparations were used,
it became clear that the pilV mutants had reduced levels of
associated PilC, which was restored to normal levels in the
complemented mutant (Fig. 4D). As a negative control, pili from
a pilC1, pilC2, pilT triple mutant were included. The inclusion of
the pilT mutation was necessary because the pilC1, pilC2 back-
ground alone fails to express Tfp (13). Remarkably, this prep-
aration lacked PilV although the protein was present in normal
levels in the whole cell lysate sample (Fig. 4 A and C, lane 6). This
finding showed that PilC is required for the capacity of PilV to
copurify with Tfp and implies that PilV antigen copurification in
the other backgrounds is likely to be due to specific interactions
and not contamination from other cellular fractions.
Attempts at quantitating the relative levels of PilC in pilus
preparations by immunoblotting were complicated by the non-
linear responsiveness associated with the enzyme-amplified im-
munodetection system used and potential differences in PilC
immunogenicity in the pilV mutants. To circumvent these prob-
lems, PilC was directly detected by using colloidal silver staining
of protein onto blotted poly(vinylidene difluoride) filter mem-
branes (Fig. 4E). Relative quantitation was achieved by com-
parison of the band intensity of the mutants to that seen for serial
dilutions of Tfp preparations from the wild-type strain mixed
with preparations from the pilC, pilT mutant (data not shown).
This method demonstrated that, relative to wild-type Tfp, PilC
levels were reduced between 4- to 6-fold in the pilVG-1 fs mutant,
8- to 10-fold in the pilV::kan mutant, and 2- to 4-fold in the pilT
mutant. There was therefore a clear discrepancy between the
marginal differences in copurifying PilC levels in the pilT and
pilV
G-1 fs
mutants and the dramatic differences in their adherence
proficiencies (Table 1).
Discussion
N. gonorrhoeae Tfp play a critical role in colonizing the human
host by promoting adherence to epithelial tissues. For most pilus
colonization factors, the filamentous appendages appear to
function primarily in the display of adhesin molecules in forms
capable of binding specific host cell receptors. Accordingly,
gonococcal mutants failing to express Tfp fibers, as well as
piliated mutants lacking the Tfp-associated adhesin PilC, both
have severe defects in binding to cells of human origin (5, 12, 13).
Here, we discovered that the pilin subunit-like protein PilV is
essential for Tfp-mediated epithelial cell adherence but dispens-
able for pilus expression. In addition, pilV mutants do not express
reduced levels of piliation as assessed by quantitative techniques.
Moreover, because free Tfp fibers from mutants failed to bind
to human epithelial cells and because mutants carrying a con-
current mutation in pilT failed to adhere, the defect associated
with the loss of PilV cannot be attributed directly to defects in
pilus anchoring to the bacterial cell, fiber fragility, or unstable
expression because of organelle retraction. These observations
demonstrate that PilV promotes the intrinsic adhesive properties
of Tfp fibers for human cell receptors.
The mechanism by which PilV contributes to adherence
remains obscure, particularly because both the pilin subunit PilE
and PilC proteins have been shown to possess human epithelial
cell-binding activities. In contrast to the situation with PilC,
however, there is currently no direct evidence that the PilE
activity has relevance to pilus-mediated bacterial adherence. We
chose then to focus this discussion with the assumption that PilC
is a pilus-associated adhesin, a position we feel is warranted by
current literature and the findings made here. It is formally
possible that PilV acts as an adhesin and that both it and PilC are
required for efficient adherence. This possibility would be
compatible with present data in the literature on PilC adhesin
activity. Given that purified mutant pili retain associated PilC
but at diminished levels, two other mutually nonexclusive ex-
planations can be envisioned. In one case, PilV might function
in efficient PilC incorporation or association with Tfp fibers, in
which case reduced adherence relates to reduced amounts of
associated PilC. Secondly, PilV may be required for proper
modification or exposure of PilC within Tfp fibers. This potential
explanation is supported by the dramatic differences in adher-
ence found for the pilT and pilVG-1 fs mutants although their
isolated pili have only minor differences in levels of associated
PilC (Table 1 and Fig. 4 D and E). At present, however, it is
impossible to differentiate between these possibilities or to
ascribe the adhesive defect to either quantitative or qualitative
alterations in PilC. Interestingly, Scheuerpflug et al. (8) reported
that addition of purified PilC was able to impart human epithelial
cell adherence to inert particles coated with PilC-deficient pili
produced in N. gonorrhoeae or P. aeruginosa but noted that
binding of complemented gonococcal pili produced in P. aerugi-
nosa was detectably weaker. This finding led them to state that
they could not ‘‘exclude the possibility that additional factors in
gonococcal pili facilitated the proper presentation of adhesive
PilC.’’
The concept that pilus adhesin activity might be influenced by
ancillary factors physically associated with the organelle has
clear precedents. In the E. coli Pap fimbrial system, PapE and
PapF are pilin-like molecules, associated with the pilus as
components of the tip fibrillum, that are required for proper
localization and, thus, function of the PapG adhesin. Mutant
cells lacking PapE retain binding ability whereas pili prepared
from this background lack it and PapF mutants are devoid of
both bacterial cell and purified pilus receptor binding activities
(28). Although PilV copurifies with Tfp during repeated rounds
of solubilization and precipitation, we have as yet been unable to
demonstrate that it is an integral part of the fiber or constitutes
a structural subcomponent such as the tip fibrillum. However the
fact that copurification of PilV is reliant on PilC, which is a
known fiber-associated protein, strongly suggests that PilC, PilV,
and Tfp interact with one another and that PilV pilus association
is not merely due to leakage from the cells and nonspecific
association. Additionally, it has been found in N. meningitidis
that one isoform of PilC (PilC2) is associated with a piliated,
nonadherent phenotype (29). Because we have shown that PilC
is necessary for the association of PilV with Tfp, we speculate























that the lack of adherence imparted by that pilC allele may result
from reduced levels of pilus-associated PilV.
Adhesin activity might also be influenced by the major pilus
subunit as has been seen in some instances. In the Salmonella
type 1 fimbrial system, it was reported that receptor specificity
of the associated FimH adhesin is influenced by the fimbrial
shaft protein subunit (30). Similarly, receptor specificity of the
sialic acid E. coli adhesin SfaS appears to be variable depending
on the fimbrial subunit with which it is associated (31). Studies
in pathogenic neisseria species have suggested a role for the pilin
subunit PilE in epithelial cell interaction because changes in its
primary structure arising via antigenic variation have been
reported to influence adherence proficiencies and tissue tropism
(12, 14–16). Given their structural identities in the amino
terminal domains thought to be crucial to subunit–subunit
contact, one explanation might relate to the differing capacities
of altered PilE protein and PilV to interact productively with one
another, leading to reduced or defective PilV activity. It is
important to note here that, with the exception of studies of Virji
and colleagues (26), none of the former studies have examined
the levels of Tfp-associated PilC or the intrinsic adherence
properties of Tfp alone. Thus, reduced PilC levels in pili or
defects in pilus anchoring might account for the findings for the
different pilE and pilC alleles. Whatever the case, it would seem
important to ascertain whether levels of fiber-associated PilV
vary in these backgrounds.
In summary, the PilV protein was identified as a pilin-like
molecule involved in gonococcal Tfp-mediated adherence to
human epithelial cells. In addition, this molecule copurifies with
Tfp and this association requires the PilC adhesin. The paradigm
established in enterobacterial chaperone-usher fimbrial systems
in which pilin-like molecules contribute to pilus adherence
function can therefore be extended to encompass the gonococcal
Type IV pilus systems. This situation is particularly remarkable
because these two pilus families use highly unrelated pathways
and components for biogenesis. Knowing that gonococcal Tfp-
mediated adherence to human epithelial cells requires minimal
expression of PilE, PilC, and PilV, it will be important to
establish how these three components act in concert to create the
adhesive phenotype. PilE is highly antigenically variable and
encoded by multiple genes, PilC is highly polymorphic and
encoded by a two-gene family, whereas pathogenic Neisseria
genomes contain only one pilV allele. Given the potentially
limited genetic diversity of PilV, elucidation of its structure and
function and the nature of its association with both PilC and Tfp
may lead to novel strategies for preventing neisserial disease.
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